Inovio Pharmaceuticals Inc INO

NAS: INO | ISIN: US45773H2013 18:39

11,34 USD (-5,50%)

(-5,50%) 18:39

Grafiek Inovio Pharmaceuticals Inc

Grafiek Inovio Pharmaceuticals Inc

1 dag1d -5,50%
1 week1w -0,18%
1 maand1m 13,17%
3 maanden3m 38,80%
6 maanden6m 2.600,00%
1 jaar1j 1.586,25%
5 jaar5j 242,60%

Inovio Pharmaceuticals Inc in het nieuws

Toon enkel gratis nieuws

13 mei 2024 · INOVIO Reports First Quarter 2024 Financial Results and Recent Business Highlights · Persbericht

1 mei 2024 · INOVIO Reports Inducement Grants Under Inducement Plan · Persbericht

29 april 2024 · INOVIO to Participate in Upcoming Investor Conferences in May · Persbericht

29 april 2024 · INOVIO to Report First Quarter 2024 Financial Results on May 13, 2024 · Persbericht

16 april 2024 · INOVIO Announces Pricing of Approximately $36 Million Underwritten Offering of Common Stock and Pre-Funded Warrants · Persbericht

26 maart 2024 · INOVIO to Participate in The Citizens JMP Novel Therapeutics Forum at Penn Medicine · Persbericht

6 maart 2024 · INOVIO Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights · Persbericht

6 maart 2024 · Geneos Therapeutics to Present New Clinical Data on GNOS-PV02 at the 2024 American Association for Cancer Research (AACR) Annual Meeting · Persbericht

21 februari 2024 · INOVIO to Report Fourth Quarter and Year-End 2023 Financial Results on March 6, 2024 · Persbericht

7 februari 2024 · INOVIO to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference · Persbericht

Profiel Inovio Pharmaceuticals Inc

Gezondheidstechnologie

Medische Specialiteiten

Productie van wapens en munitie

Website: www.inovio.com

Hoofdzetel: San Diego, California Verenigde Staten

CEO: Jong Kim

Werknemers: 309

Aandelen Inovio Pharmaceuticals Inc

Beurswaarde: 310,93 miljoen USD

Effecten: 25,91 miljoen

Winst per aandeel (12 maand): PLUS

Beta: 1,64

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe